Article ID Journal Published Year Pages File Type
2743607 Anaesthesia & Intensive Care Medicine 2009 4 Pages PDF
Abstract

An allograft is tissue transplanted from another individual within the same species. Mechanical trauma to a graft and recipient transplant site along with graft-derived proinflammatory mediators stimulate a non-specific innate immune response. Dendritic cells and macrophages present foreign antigen to the adaptive immune system cells and thus initiate a specific and directed response. In order to respond to a specific pathogen, an individual must be able to recognize foreign cells as non-self. Major and minor histocompatibility antigens (MHCs) and the ABO blood group antigens are central to distinguishing one human from another and therefore in recognizing self from non-self. Genetic polymorphism describes genes encoded by varying alleles resulting in varied phenotypes within a species. The blood group and MHC are polymorphic, with many different possible allelic combinations leading to differences between individuals and allowing an individual to recognize self from non-self. Rejection describes the graft injury and loss of function due to the recipient’s non-acceptance of the graft as ‘self’ and the response which aims to remove it from the body. Rejection can be classified into hyperacute, acute and chronic states. Both cell-mediated and antibody-mediated mechanisms lead to allograft tissue destruction. By minimizing MHC mismatch and using immunosuppression therapy, the immune response to a graft can be reduced. This involves familial grafting when possible, matching donors and recipients for similar human leucocyte antigen and identification of preformed recipient antibodies.

Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Authors
, ,